Article
CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing.
Pharmacogenetics and genomics - 1 Jan 2016
Wang Danxin, Sadee Wolfgang
Abstract excerpt
Cytochrome P450 3A4 (CYP3A4) metabolizes 30-50% of clinically used drugs. Large interperson variability in CYP3A4 activity affects response to CYP3A4 substrate drugs. We had demonstrated that an intronic single nucleotide polymorphism rs35599367 (CYP3A4*22, located in intron 6) reduces mRNA/protein expression; however, the underlying mechanism remained unknown. Here we show that CYP3A4*22 is associated with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
